Form 4: Hologic Director Martin D. Madaus Acquires Shares in Recent Transaction

Director Martin D. Madaus purchased 5,445 shares of Hologic Inc. common stock at an average price of $55.236 on May 7, 2025.

Summary

• On May 7, 2025, Martin D. Madaus, a director of Hologic Inc., acquired 5,445 shares of common stock.
• The shares were purchased at a weighted average price of $55.236 per share, with individual prices ranging from $55.14 to $55.30.
• Following the transaction, Mr. Madaus directly owns 2,206 shares and indirectly owns 5,445 shares through a revocable trust.
• The reporting person will provide full information regarding the number of shares sold at each price upon request.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a routine transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider trading activity is closely monitored and can influence investor sentiment. Purchases by directors are often viewed positively.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Hologic, HOLX, Insider Trading, Form 4, Stock Acquisition, Martin D. Madaus, Director